http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100545730-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F21S8-06
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F21V15-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F21V3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F21S8-061
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-65
filingDate 2004-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100545730-B1
titleOfInvention Urine component analysis system using Raman spectroscopy and its method
abstract The present invention provides a Raman spectrometer unit for emitting a laser beam to a predetermined sample and receiving the light scattered from the sample to obtain a spectrum by Raman spectroscopy; A training set module for storing spectrum and clinical component information of one or more samples; A calibration component which analyzes each spectrum by a pretreatment process, calculates a score and a loading vector for each component to be measured in the sample by a PLS method, and constructs a calibration model by cross-validation; A test sample module for storing a spectrum of a test sample obtained by using a Raman spectrometer unit; A component analyzer configured to analyze the spectrum of the test sample module by a pretreatment process and predict component concentrations of the test sample by using parameters of the calibration model; And a validity determiner configured to determine the validity of at least one of the Mahalanobis distance method, the spectral residual, the f-raso, and the F test with respect to the results of the calibration component and the component analyzer to select the component information of the test sample. Provided is a component analysis system using Raman spectroscopy comprising a. According to the present invention, the urine test can be performed involuntarily without visiting the hospital, so that the condition of the patient can be continuously monitored for a long time.n n n n Raman spectroscopy, urine, laser
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102455161-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220146049-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010002123-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010002123-A2
priorityDate 2004-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451822344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22227373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176

Total number of triples: 25.